| The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study WA Faubion Jr, EV Loftus Jr, WS Harmsen, AR Zinsmeister, WJ Sandborn Gastroenterology 121 (2), 255-260, 2001 | 1512 | 2001 |
| Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas WA Faubion, ME Guicciardi, H Miyoshi, SF Bronk, PJ Roberts, ... The Journal of clinical investigation 103 (1), 137-145, 1999 | 666 | 1999 |
| Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease W Afif, EV Loftus Jr, WA Faubion, SV Kane, DH Bruining, KA Hanson, ... Official journal of the American College of Gastroenterology| ACG 105 (5 …, 2010 | 607 | 2010 |
| Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation MA Kleinschek, K Boniface, S Sadekova, J Grein, EE Murphy, SP Turner, ... Journal of Experimental Medicine 206 (3), 525-534, 2009 | 563 | 2009 |
| Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial CA Solem, EV Loftus Jr, JG Fletcher, TH Baron, CJ Gostout, BT Petersen, ... Gastrointestinal endoscopy 68 (2), 255-266, 2008 | 433 | 2008 |
| Treatment of eosinophilic esophagitis with inhaled corticosteroids WA Faubion Jr, J Perrault, LJ Burgart, NN Zein, ML Clawson, DK Freese Journal of pediatric gastroenterology and nutrition 27 (1), 90-93, 1998 | 410 | 1998 |
| JAK–STAT pathway targeting for the treatment of inflammatory bowel disease A Salas, C Hernandez-Rocha, M Duijvestein, W Faubion, D McGovern, ... Nature reviews Gastroenterology & hepatology 17 (6), 323-337, 2020 | 401 | 2020 |
| Development of chronic colitis is dependent on the cytokine MIF YP De Jong, AC Abadia-Molina, AR Satoskar, K Clarke, ST Rietdijk, ... Nature immunology 2 (11), 1061-1066, 2001 | 380 | 2001 |
| Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children JS Hyams, A Griffiths, J Markowitz, RN Baldassano, WA Faubion Jr, ... Gastroenterology 143 (2), 365-374. e2, 2012 | 328 | 2012 |
| Death receptors in liver biology and pathobiology WA Faubion, GJ Gores Hepatology 29 (1), 1-4, 1999 | 291 | 1999 |
| Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression H Ji, G Liao, WA Faubion, AC Abadía-Molina, C Cozzo, FS Laroux, ... The Journal of Immunology 172 (10), 5823-5827, 2004 | 286 | 2004 |
| The Epidemiology of Clostridium difficile Infection in Children: A Population-Based Study S Khanna, LM Baddour, WC Huskins, PP Kammer, WA Faubion, ... Clinical infectious diseases 56 (10), 1401-1406, 2013 | 259 | 2013 |
| The cell surface receptor SLAM controls T cell and macrophage functions N Wang, A Satoskar, W Faubion, D Howie, S Okamoto, S Feske, C Gullo, ... The Journal of experimental medicine 199 (9), 1255-1264, 2004 | 243 | 2004 |
| biological activity markers in inflammatory bowel disease D Desai, WA Faubion, WJ Sandborn Alimentary pharmacology & therapeutics 25 (3), 247-255, 2007 | 238 | 2007 |
| Infliximab is not associated with increased risk of malignancy or hemophagocytic lymphohistiocytosis in pediatric patients with inflammatory bowel disease JS Hyams, MC Dubinsky, RN Baldassano, RB Colletti, S Cucchiara, ... Gastroenterology 152 (8), 1901-1914. e3, 2017 | 216 | 2017 |
| SLAM is a microbial sensor that regulates bacterial phagosome functions in macrophages SB Berger, X Romero, C Ma, G Wang, WA Faubion, G Liao, E Compeer, ... Nature immunology 11 (10), 920-927, 2010 | 201 | 2010 |
| Autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease AB Dietz, EJ Dozois, JG Fletcher, GW Butler, D Radel, AL Lightner, ... Gastroenterology 153 (1), 59-62. e2, 2017 | 196 | 2017 |
| Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures S Samuel, DH Bruining, EV Loftus Jr, KT Thia, KW Schroeder, ... Clinical Gastroenterology and Hepatology 11 (1), 49-54. e1, 2013 | 182 | 2013 |
| Challenges in pediatric inflammatory bowel disease A Bousvaros, F Sylvester, S Kugathasan, E Szigethy, C Fiocchi, R Colletti, ... Inflammatory bowel diseases 12 (9), 885-913, 2006 | 176 | 2006 |
| Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab W Afif, JA Leighton, SB Hanauer, EV Loftus Jr, WA Faubion, DS Pardi, ... Inflammatory bowel diseases 15 (9), 1302-1307, 2009 | 163 | 2009 |
